17β-estradiol inhibits the production of interferon-induced protein of 10 kDa by human keratinocytes

Journal of Investigative Dermatology

Volumn 120, Issue 3, 2003, Pages 411-419

  Kanda, Naoko ^a   Watanabe, Shinichi ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

3 ,5 adenosine cyclic monophosphate; Psoriasis; Signal transducer and activator of transcription 1

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 17ALPHA ESTRADIOL; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ANTIESTROGEN; BOVINE SERUM ALBUMIN CONJUGATED 17BETA ESTRADIOL; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; JANUS KINASE; MESSENGER RNA; PHOSPHATE; SEX HORMONE; STAT1 PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG; ALPHA CHEMOKINE; CXC CHEMOKINE IP 10; CXC CHEMOKINE IP-10; CYCLIC AMP; GAMMA INTERFERON ACTIVATION FACTOR; INSULIN; INTERFERON STIMULATED GENE FACTOR 3; JAK1 PROTEIN, HUMAN; JAK2 PROTEIN, HUMAN; JANUS KINASE 1; JANUS KINASE 2; ONCOPROTEIN; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; TYROSINE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; KERATINOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; BINDING SITE; CELL CULTURE; DNA RESPONSIVE ELEMENT; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

BINDING SITES; CELLS, CULTURED; CHEMOKINES, CXC; CYCLIC AMP; ESTRADIOL; GONADAL STEROID HORMONES; HUMANS; INSULIN; INTERFERON TYPE II; INTERFERON-STIMULATED GENE FACTOR 3; JANUS KINASE 1; JANUS KINASE 2; KERATINOCYTES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RESPONSE ELEMENTS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TYROSINE;

EID: 0037336384     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12066.x     Document Type: Article

References (60)

1. Arnold WP, Pennings BJH, van der Kerkhof PCM: The induction of epidermal orinithine decarboxylase following UV-B irradiation is inhibited by estriol. Acta Derm Venereol (Stockh) 73:92-93, 1993
2. Aronica SM, Kraus WL, Katzenellenbogen BS: Estrogen action via the cAMP signaling, pathway stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91:8517-8521, 1994
3. Beato M: Gene regulation by steroid hormones. Cell 56:335-344, 1989
4. Benten WPM, Bettenhaeuser U, Wunderlich F, van Vliet E, Mossmann H: Testosterone-induced abrogation of self-healing of Plasmodium chabaudi malaria in B10 mice: mediation by spleen cells. Infect Immun 59:4486-4490, 1991
5. Benten WPM, Lieberherr M, Giese G, Wunderlich F: Estradiol binding to cell surface raises cytosolic free calcium in T cells. FEBS Lett 422:349-353, 1998
6. Berry M, Metzger D, Chambon P: Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 9:2811-2818, 1990
7. Beyer C, Karolczak M: Estrogenic stimulation of neurite growth in midbrain dopaminergic neurons depends on cAMP/protein kinase A signaling. J Neurosci Res 59:107-116, 2000
8. Bluyssen HAR, Muzaffar R, Vlieststra RJ, et al: Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses. Proc Natl Acad Sci USA 92:5645-5649, 1995
9. Boorsma DM, Flier J, Sampat S, et al: Chemokine IP-10 expression in cultured human keratinocytes. Arch Dermatol Res 290:335-341, 1998
10. Bos JD, de Rie MA: The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today 20:40-46, 1999
11. Bouchard P, Zhao Z, Banville D, Dumas F, Fischer EH, Shen S-H: Phosphorylation and identification of a major tyrosine phosphorylation site in protein tyrosine phosphatase 1C. J Biol Chem 269:19585-19589, 1994
12. Boyd AS, Morris LF, Phillips CM: Psoriasis and pregnancy: hormone and immune system interaction. Int J Dermatol 35:169-172, 1996
13. Breier-Maly J, Ortel B, Breier F, Schmidt JB, Honigsmann H: Generalized pustular psoriasis of pregnancy (impetigo herpetiformis). Dermatology 198:61-64, 1999
14. Catalan RE, Gargiulo L, Martinez AM, Calcerrada MC, Liras A: Protein tyrosine phosphatase activity modulation by endothelin-1 in rabbit platelets. FEBS Lett 400:280-284, 1997
15. Choi EJ, Xia Z, Storm DR: Stimulation of the type III olfactory adenylyl cyclase by calcium and calmodulin. Biochemistry 31:6492-6498, 1992
16. Correale J, Arias M, Gilmore W: Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 161:3365-3374, 1998
17. David M, Petricoin E III, Larner AC: Activation of protein kinase A inhibits interferon induction of the Jak/Stat pathway in U266 cells. J Biol Chem 271:4585-4588, 1996
18. Delgado M, Ganea D: Inhibition of IFN-γ-induced Janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. J Immunol 165:3051-3057, 2000
19. Dunna SF, Finlay AV: Psoriasis: improvement during and worsening after pregnancy. Br J Dermatol 120:584, 1989 (Letter)
20. Epstein PM, Mills JS, Hersh EM, Strada SJ, Thompson WJ: Activation of cyclic nucleotide phosphodiesterase from isolated human peripheral blood lymphocytes by mitogenic agents. Cancer Res 40:379-386, 1980
21. Farber EM, Nall ML: The natural history of psoriasis in 5,600 patients. Dermatologica 148:1-18, 1974
22. Farhat MY, Abi-Younes S, Dingaan B, Vargas R, Ramwell PW: Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism. J Pharmacol Exp Ther 276:652-657, 1996
23. Fissore F, Fortunati N, Comba A, Fazzari A, Gaidano G, Berta L, Frairia R: The receptor-mediated action of sex steroid binding protein (SPB, SHBG): accumulation of cAMP in MCF-7 cells under SBP and estradiol treatment. Steroids 59:661-667, 1994
24. Flier J, Boorsma DM, Bruynzeel DP, et al: The CXCK3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions. J Invest Dermatol 113:574-578, 1999
25. Genever PG, Maxfield SJ, Kennovin GD, Maltman J, Bowgen CJ, Raxworthy MJ, Skerry TM: Evidence for a novel glutamate-mediated signaling pathway in keratinocytes. J Invest Dermatol 112:337-342, 1999
26. Giustizieri ML, Mascia F, Freaaolini A, et al: Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 107:871-877, 2001
27. Ivashkiv LB, Schmitt EM, Castro A: Inhibition of transcription factor Stat1 activity in mononuclear cell cultures and T cells by the cyclic AMP signaling pathway. J Immunol 157:1415-1421, 1996
28. Kanda N, Watanabe S: 17β-estradiol enhances vascular endothelial growth factor production and dihydrotestosterone antagonizes the enhancement via the regulation of adenylate cyclase in differentiated THP-1 Cells. J Invest Dermatol 118:519-529, 2002
29. 2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431. J Invest Dermatol 119:1080-1089, 2002
30. Kaplan AP: Chemokines, chemokine receptors, and allergy. Int Arch Allergy Immunol 124:423-431, 2001
31. Kim HP, Lee JY, Jeong JK, Bae SW, Lee HK, Jo I: Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor α localized in caveolae. Biochem Biophys Res Commun 263:257-262, 1999
32. Lee EH, Rikihisa Y: Protein kinase-A-mediated inhibition of gamma interferon-induced tyrosine phosphorylation of Janus kinases and latent cytoplasmic transduction factors in human monocytes by Ehrlichia chaffeensis. Infect Immun 66:2514-2520, 1998
33. Machado JD, Alonso C, Morales A, Gomez JF, Borges R: Nongenomic regulation of the kinetics of exocytosis by estrogens. J Pharmacol Exp Ther 301:631-637, 2002
34. Majumder S, Zhou LS-H, Chaturvedi P, Babcock G, Aras S, Ransohoff RM: p48/STAT-1α-containing complexes play a predominant role in induction of IFN-γ-inducible protein, 10 kDa (IP-10) by IFN-γ alone or in synergy with TNF-α. J Immunol 161:4736-4744, 1998
35. Matejuk A, Adlard K, Zamora A, Silverman M, Vanderbark AA, Offner H: 17β-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J Neurosci Res 65:529-542, 2001
36. Meloche S, Pelletier S, Servant MJ: Functional cross-talk between the cyclic AMP and Jak/STAT signaling pathways in vascular smooth muscle cells. Mol Cell Biochem 212:99-109, 2000
37. ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15:1292-1300, 1996
38. Mowad CM, Margolis DJ, Halpern AC, Suri B, Synnestvedt M, Guzzo CA: Hormonal influences on women with psoriasis. Cutis 61:257-260, 1998
39. Nakla AM, Khan MS, Romas NA, Rosner W: Estradiol causes the rapid accumulation of cAMP in human prostate. Proc Natl Acad Sci USA 91:5402-5405, 1994
40. Ohmori Y, Hamilton TA: Cooperative interaction between interferon (IFN) stimulus response clement and κB sequence motifs controls IFNγ- and lipopolysaccharide-stimulated transcription from the murine IP-10 promoter. J Biol Chem 268:6677-6688, 1993
41. Ohmori Y, Tebo J, Nedospasov S, Hamilton TA: κB binding activity in a murine macrophage-like cell line Sequence-specific differences in κB binding and transcriptional activation functions. J Biol Chem 269:17684-17690, 1994
42. Ohmori Y, Schreiber RD, Hamilton TA: Synergy between interferon-γ and tumor necrosis factor-α in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor κB. J Biol Chem 272:14899-14907, 1997
43. Paech K, Webb P, Kuiper GGJM, et al: Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277:1508-1510, 1997
44. Papas TC, Gametchu B, Watson CS: Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J 9:404-410, 1995
45. Razandi M, Pedram A, Greene GL, Levin ER: Cell membrane and nuclear estrogen receptors (ER) originate from a single transport: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol 13:307-319, 1999
46. Roberson EF, Sweatt JD: Transient activation of cyclic AMP-dependent protein kinase during hippocampal long-term potentiation. J Biol Chem 271:30436-30441, 1996
47. Robicsek SA, Blanchard DK, Djeu JY, Krzanowski JJ, Szentivany A, Polson JB: Multiple high-affinity cAMP-phosphodiesterase in human T-lymphocytes. Biochem Pharmacol 42:869-877, 1991
48. Rocchi S, Gaillard I, van Obberghen E, Chambaz EM, Vilgrain I: Adrenocorticotrophic hormone stimulates phosphotyrosine phosphatase SHP2 in bovine adrenocortical cells. Phosphorylation and activation by cAMP-dependent protein kinase. Biochem J 352:483-490, 2000
49. Rottman JB, Smith TL, Ganley KG, Kikuchi T, Krueger JG: Potential role of the chemokine receptors CXCR3, CCR4, and the integrin αEβ7 in the pathogenesis of psoriasis vulgaris. Lab Invest 81:335-347, 2001
50. Salomon AB, Londons D, Rodbell M: A highly sensitive adenylate cyclase assay. Anal Biochem 58:541-548, 1974
51. Sengupta TK, Schmitt EM, Ivashikiv LB: Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways. Proc Natl Acad Sci USA 93:9499-9504, 1996
52. Spangler AS, Antoniades HN, Sotman SL, Inderbitizin TM: Enhancement of the anti-inflammatory action of hydrocortisone by estrogen. J Clin Endocr 29:650-655, 1969
53. Stefano GB, Prevot V, Beauvillain J-C, et al: Estradiol coupling to human monocyte nitric oxide release is dependent on intracellular calcium transients: evidence for an estrogen surface receptor. J Immunol 163:3758-3763, 1999
54. Swanbeck G, Inerot A, Martinsson T, Wahlstrom J: A population genetic study of psoriasis. Br J Dermatol 131:32-39, 1994
55. Takano N, Iizuka N, Hazama S, Yoshino S, Tangoku A, Oka M: Expression of estrogen receptor-α and -β mRNAs in human gastric cancer. Cancer Lett 176:129-135, 2002
56. 2 in human prostatic carcinoma cells. Br J Cancer 75:1111-1118, 1997
57. Vaughan Jones SA, Hern S, Nelson-Piercy C, Seed PT, Black MM: A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles. Br J Dermatol 141:71-81, 1999
58. Wade CB, Robinson S, Shapiro RA, Dorsa DM: Estrogen receptor (ER) α and ERβ exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway. Endocrinology 142:2336-2342, 2001
59. Woolley CS, McEwen BS: Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci 14:7680-7687, 1994
60. Zellmer S, Gaunitz F, Salvetter J, Surovoy A, Reissig D, Gebhardt R: Long-term expression of foreign genes in normal human epidermal keratinocytes after transfection with lipid/DNA complexes. Histochem Cell Biol 115:41-47, 2001